HomeABVC • NASDAQ
ABVC Biopharma Inc
add
Market news
ORCL
6.31%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.29M | 134.89% |
Net income | -2.26M | -139.51% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.29M | -170.23% |
Effective tax rate | -1.02% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 453.46K | 126.75% |
Total assets | 16.24M | 10.98% |
Total liabilities | 6.75M | -0.79% |
Total equity | 9.49M | — |
Shares outstanding | 22.81M | — |
Price to book | 7.68 | — |
Return on assets | -36.88% | — |
Return on capital | -50.99% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -2.26M | -139.51% |
Cash from operations | -894.17K | -322.93% |
Cash from investing | -665.78K | -32.73% |
Cash from financing | 1.93M | 140.27% |
Net change in cash | 316.76K | 278.14% |
Free cash flow | -409.71K | 46.69% |
Previous close
$2.84
Day range
$2.73 - $2.89
Year range
$0.40 - $5.48
Market cap
67.57M USD
Avg Volume
110.01K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Website
Employees
18